Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Enbrel phase III and long-term safety data presented at rheumatology meeting

Nov. 20, 1997

New VCAM-1 inhibitor isolated from marine sponge

Nov. 19, 1997

rhIL-11 effective in rats with adjuvant arthritis

Nov. 19, 1997

rhIL-10 evaluated for safety and efficacy in RA patients

Nov. 19, 1997

Complement activation inhibitors prepared at U of Pennsylvania

Nov. 19, 1997

Second-generation, highly selective COX-2 inhibitors developed at Merck

Nov. 18, 1997

Safety, immunogenicity and efficacy of anti-TNF antibody in RA patients

Nov. 18, 1997

COX-2 antisense therapy for rheumatoid arthritis

Nov. 18, 1997

Improvement in early and established arthritis with antiangiogenic therapy

Nov. 18, 1997

Potential of rhM-CIF in rheumatoid arthritis suggested by animal studies

Nov. 18, 1997

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...